Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
AUTOLUS THERAPEUTICS PLC
About AUTL
Autolus Therapeutics plc is a United Kingdom-based early commercial-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. The Company has an approved commercial product, AUCATZYL, for the treatment of adult patients with r/r B-ALL. Using a suite of proprietary and modular T cell programming technologies, it is also developing five programs in seven hematological and solid tumor indications and one autoimmune indication. It is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and attack and eliminate these cells. Its product pipeline includes obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting TRBC 1 and TRBC 2.
Find out what a historical investment in AUTOLUS THERAPEUTICS PLC would be worth today using our AUTL stock calculator.
Market Capitalisation
$433.83M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.48M
High today
$1.63
Low today
$1.53
Open price
$1.58
52-week high
$2.70
52-week low
$1.18
Ready to start your investing journey with Stake?
Open an accountHow do I buy AUTL shares in Australia?
Buying AUTL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in AUTOLUS THERAPEUTICS PLC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AUTL
What is the ticker symbol of AUTOLUS THERAPEUTICS PLC?
The ticker symbol for AUTOLUS THERAPEUTICS PLC is AUTL.
How much is one share of AUTL?
One share of AUTL is valued at $1.61 as of 17 May 2026.
What is the market capitalisation of AUTOLUS THERAPEUTICS PLC AUTL?
As of 17 May 2026 AUTOLUS THERAPEUTICS PLC has a market cap of $433.83M.
What is the 52-week high for AUTOLUS THERAPEUTICS PLC stock?
The AUTOLUS THERAPEUTICS PLC 52-week high stock price is $2.70.
What is the 52-week low for AUTOLUS THERAPEUTICS PLC stock?
The AUTOLUS THERAPEUTICS PLC 52-week low stock price is $1.18.
Can I buy AUTL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AUTL shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AUTL on Stake
- Buy AUTL from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AUTL from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AUTL related stocks